3+3 Design [Design Issues]

posted by Pharma_88 – China, 2020-01-07 08:09  – Posting: # 21062
Views: 342

Hello All,

This is regarding 3+3 design for Phase-I trial. I have searched online and found some articles on design. My Question is that once the group/cohort is completed with 3 patients, whether same patients will be enrolled in next cohort or new patient will be enrolled? Further, in next cohort suppose 1 patient is withdarwn or have some AE then its compulsory to add 3 more patients to inline with multiplication of 3?

Thanks,
Pharma_88

Complete thread:

Activity
 Admin contact
20,242 posts in 4,259 threads, 1,395 registered users;
online 12 (0 registered, 12 guests [including 8 identified bots]).
Forum time (Europe/Vienna): 04:22 CET

Not to be absolutely certain is, I think,
one of the essential things in rationality.    Bertrand Russell

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5